Source: EURLEX
Language: en
Format: md

[**Avis juridique important**](../../../editorial/legal_notice.htm)

*|*

# 91996E2463

**WRITTEN QUESTION No. 2463/96 by Mary BANOTTI to the Commission. Radiation risk experiments** 
  
*Official Journal C 083 , 14/03/1997 P. 0018*

  

WRITTEN QUESTION E-2463/96 by Mary Banotti (PPE) to the Commission (23 September 1996)

Subject: Radiation risk experiments

Is it correct to interpret the answer given to written question E-0560/96 ((OJ C185, 25.6.1996, p. 71. )) as suggesting that persons who were involved in formulating the EU policy of research objectives in this area also participated either directly or through their associated laboratories in receiving funding under the radiation protection programme?

Is it also correct to interpret the answer given as suggesting that the same tumour suppressor genes (for example p53) are as important in inbred mice as in long-lived humans?

Is it also correct to interpret the answer given as suggesting that similar specific genetic alterations in mice and humans produce tumours of comparable location and pathology?

Answer given by Mrs Cresson on behalf of the Commission (20 November 1996)

Those who advise the Commission on the choices of research priorities are not necessarily excluded from submitting research project proposals to Community research programmes provided there is no conflict of interest. For the selection of projects, the Commission is assisted by independent expert evaluators, whose task is to examine all competing proposals on strict quality criteria.

It was not the intention to suggest that the same tumour suppressor genes are as important in imbred mice as in longer lived humans nor to suggest that similar specific genetic alterations in mice and humans produce tumours of comparable location and pathology. The research is based on the widely held assumption that the carcinogenic process, and the influence of radiation on it, is comparable in different mammalian species.

[Top](#document1)